Cerevance’s $36 Million Round Funding

A Goodwin cross-border team represented the neuroscience company Cerevance in its launch by Lightstone Ventures and Takeda Pharmaceutical. Cerevance will focus on discovering and developing novel…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now